Marsh McLennan (MRSH) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
27 Feb, 2026Executive summary
Achieved $27.0 billion in revenue for 2025, representing 10% total growth and 4% underlying growth, with operations in 130 countries and over 95,000 employees.
Adjusted operating income grew 11% year-over-year; adjusted EPS increased 9% to $9.75.
Maintained strong recurring revenue, high client retention, and a capital-light business model generating substantial free cash flow.
Completed integration of McGriff, launched new Marsh brand and Thrive program, and executed $2B in share repurchases.
Thrive program focuses on growth, efficiency, and investment in AI, digital infrastructure, and talent.
Financial highlights
Q4 consolidated revenue increased 9% to $6.6B, with 4% underlying growth.
Adjusted operating income for the year was $7.3B, up 11% year-over-year; adjusted EPS $9.75.
Free cash flow totaled $5B for the year, with a 19% margin and 25% year-over-year growth.
Q4 adjusted operating income was $1.6B (+12%); Q4 adjusted EPS was $2.12, up 10% year-over-year.
Full-year net income attributable to the company was $4.2B, or $8.43 per diluted share.
Outlook and guidance
Expect underlying revenue growth in 2026 to be similar to 2025, with continued margin expansion and solid adjusted EPS growth.
Thrive program expected to deliver ~$400M in savings over three years, supporting additional margin expansion.
Anticipate adjusted effective tax rate of 24.5%-25.5% in 2026.
Plan to deploy ~$5B in capital across dividends, acquisitions, and share repurchases in 2026.
Positioned for sustained momentum in 2026, with management citing strong team performance in a complex environment.
Latest events from Marsh McLennan
- Q2 revenue up 6%, EPS up 10%, margin 29%, and dividend raised 15% amid robust growth.MRSH
Q2 20243 Feb 2026 - Q3 revenue up 6%, strong segment growth, and $7.75B McGriff acquisition announced.MRSH
Q3 202419 Jan 2026 - Strong 2024 growth, record acquisitions, and margin expansion set up a positive 2025 outlook.MRSH
Q4 20249 Jan 2026 - Q1 2025 revenue up 9%, adjusted EPS up 5%, with strong segment growth and capital returns.MRSH
Q1 202519 Dec 2025 - Strong 2024 results, robust governance, and key votes on directors, pay, auditor, and equity plan.MRSH
Proxy Filing1 Dec 2025 - Annual meeting to vote on directors, pay, auditor, and incentive plan, all board-backed.MRSH
Proxy Filing1 Dec 2025 - Q2 2025 delivered 12% revenue growth, 11% EPS gain, and a 10% dividend increase.MRSH
Q2 20255 Nov 2025 - Q3 revenue up 11%, adjusted EPS up 11%, Thrive targets $400M savings, rebranding to Marsh.MRSH
Q3 202520 Oct 2025